|
Volume 271, Number 51,
Issue of December 20, 1996
pp. 32849-32856
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Mutational Analysis of Two Highly Conserved UGG Sequences of 23 S
rRNA from Escherichia coli*
(Received for publication, July 2, 1996, and in revised form, September 12, 1996)
Christian M. T.
Spahn
,
Jaanus
Remme
§,
Markus A.
Schäfer
and
Knud H.
Nierhaus
¶
From the Max-Planck-Institut für Molekulare
Genetik, AG Ribosomen, Ihnestrasse 73, D-14195 Berlin, Germany and
the § Institute of Molecular and Cell Biology, Tartu
University, Riia 23, EE-2400 Tartu, Estonia
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
The 23 S-type rRNA contains two phylogenetically
conserved UGG sequences, which have the potential to bind the universal
CCA-3 -ends of tRNAs at the ribosomal peptidyltransferase center by
base pairing. The first two positions, UG, of these sequences at the
helix-loop 80 (U2249G2250) and helix-loop 90 ( 2580G2581) and some
related nucleotides were tested by site-directed mutagenesis for their involvement in ribosomal function, i.e.
peptidyltransferase. The plasmid-derived mutated 23 S rRNA comprised
about 50% of the total 23 S rRNA. None of the single mutations caused
an assembly defect, and all 50 S subunits carrying an altered 23 S rRNA
could freely exchange with the pools of 70S ribosomes and polysomes.
The mutations at the helix-loop 80 region hardly affected bacterial
growth. However, mutations at the helix 90 caused severe growth effects and severely impaired the in vitro protein synthesis,
showing that this 23 S rRNA region is of high importance for ribosomal function.
INTRODUCTION
The central enzymatic activity of ribosomes is the formation of
peptide bonds. The corresponding peptidyltransferase
(PTF)1 center is located on the large
ribosomal subunit (1, 2). Reconstitution analyses have identified the
ribosomal proteins L2, L3, and L4, and the 23 S rRNA as PTF candidates
in Escherichia coli ribosomes (3, 4, 5). A complex derived from
the large subunit of Thermus aquaticus ribosomes consisting
of 23 S rRNA and only 3-8 proteins had significant PTF activity (6, 7). This observation underscores the possible involvement of 23 S rRNA
in this activity.
An impressive wealth of data points to a distinct feature of the
secondary structure map of 23 S rRNA, the so-called
"peptidyltransferase ring" of domain V (8, 9) as a component at or
near the PTF center. The PTF ring comprises about 40 nucleotides and
represents a cluster of universally conserved nucleotides (10, 11). It is satisfying that a highly divergent array of methods correspondingly identifies the same region of 23 S rRNA, methods such as cross-linking studies with substrates of the PTF center (12, 13, 14, 15), mutations of the 23 S rRNA gene conferring resistance against inhibitors of the PTF
activity (for review, see Refs. 16 and 17), and protection studies
(18, 19, 20).
Some studies aimed to identify nucleotides at the PTF center. The
nucleotides G2252 and G2253, which are at the helix-loop 80, were
protected against kethoxal by the 3 -terminal CCA of P-site bound tRNA
(19). Mutation of G2252 generated a dominant lethal phenotype (21). A
double mutant having both Gs altered was lethal and showed a reduced
activity of peptide bond formation by approximately 50% (22). A recent
analysis presented evidence that G2252 is involved in canonical base
pairing with C74 at the acceptor end of tRNA, thus obviously playing a
role in the binding of the donor substrate at the P site region of the
PTF center (23).
Another study applied a random mutagenesis of the "Southern half"
of the PTF ring (residues 2493-2606). With an elegant screening procedure, 21 mutations of 18 positions were found. Mutations at three
positions blocked growth, one of which was universally conserved
( 2580). The observation that a mutation of 2580 caused a 90%
inhibition of the PTF activity led the authors to suggest that the
sequence GG2582 might be involved in the binding of the CCA-3 -end
of tRNAs at the P site (24).
Here we pursue a different strategy. Base pairing of the tRNA
CCA-3 -end with a complementary UGG sequence of 23 S rRNA is the most
likely explanation for experimental data gained with minimal substrates
(25, 26) and with tRNAs mutated in the CCA-3 -end (27) as substrates of
the P-site region of the PTF center. The 23 S rRNA contains 55 UGG
sequences, only two of which are universally conserved in
non-mitochondrial 23 S-type rRNA, and are therefore candidates for
binding the universal CCA-3 -end of tRNAs, possibly via canonical base
pairing. One of these UGG sequences is U2249 to G2251 at the helix-loop
80, and the other is 2580 to G2582 at helix 90, adjacent to the PTF
ring. The U ( ) and the middle G were mutated in both sequences, and
the effects on growth, expression, ribosomal assembly, and functions
were studied in this and the accompanying paper (28).
MATERIALS AND METHODS
Plasmids and Strains
The plasmid pNO2680 contains the
E. coli rrnB operon under the control of the leftward
promoter (29). This plasmid with the single point mutation A1067U in
the 23 S rRNA gene (30) is called pNOt. Plasmids ptac-1 and ptac-2
carry the rrnB operon or the 23 rRNA gene, respectively, under the
control of the tac-promoter (31). Plasmids ptac-1 and ptac-2 also
contain the A1067U mutation that confers thiostrepton resistance.
E. coli CJ236 (dut1, ung1, thi-1, relA1) was used for the
preparation of uracil containing single-stranded DNA template for
site-directed mutagenesis, and strain XL-1 Blue was used for
propagating the M13 derivatives as well as the plasmids ptac-1 and
ptac-2. XL-1 transformed with pCI857, which encodes the
temperature-sensitive repressor and a neomycin resistance marker,
was the host of the pNO2680 derivatives.
Site-directed Mutagenesis
The
EcoRI-BamHI fragment, containing the 3 part of
the rrnB 23 S rRNA gene, was cloned into M13mp18 and used for
oligo-directed construction (32) of the mutations U2249C, G2250A,
C2254U, C2507U, 2580C, G2581A, and G2250A/C2254U. The double
mutation C2507U/G2581A was constructed taking advantage of an M13mp18
derivative already carrying the mutation G2581A as a template for the
introduction of the second mutation, C2507U. The
EspI-PvuII fragments containing the base changes
G2581A and G2250A were cloned into ptac-1 by performing a partial
restriction of the vector with PvuII. The other mutants were
cloned into ptac-2 using BamHI and EclXI. The EspI-XbaI fragment of the mutated ptac-1 or
ptac-2 vectors was cloned into pNO2680, yielding a pNO2680 derivative
carrying the A1067U mutation as well as the mutation in domain V of the
23 S rRNA gene. All base changes were verified by DNA sequencing (33)
of the M13 inserts and the reconstructed expression vectors. The DNA
manipulations followed standard procedures (34, 35), and competent
cells for plasmid transfection were prepared according to the SEM
protocol (36).
Polysome Preparation and Quantification of Plasmid-born 23 S
rRNA
100 ml of 2 × YT (16 g/liter tryptone, 10 g/liter
yeast extract, 5 g/liter NaCl) supplemented with 0.2 mg/ml ampicillin
and 0.05 mg/ml neomycin was inoculated with XL-1/pCI857 transformed with the pNO derivatives. Cultures were grown until
A560 = 0.1 and then shifted to 42 °C. After
90 min at 42 °C, the cultures were poured over crushed ice. The
cells were pelleted and resuspended in 1 ml of buffer A (20 mM Tris-HCl (pH 8.0 at 0 °C), 6 mM
MgCl2, 100 mM KCl) containing 16% (w/v)
sucrose and lysozyme (0.5 mg/ml), and broken by freezing and thawing.
Lysates were applied onto a 10-40% sucrose gradient in binding buffer
(20 mM Hepes-KOH (pH 7.6), 6 mM
MgCl2, 150 mM NH4Cl, 4 mM -mercaptoethanol, 2 mM spermidine, and
0.05 mM spermine) and centrifuged in a Beckman SW-40 rotor for 7.5 h at 80,000 × g. Fractions of polysomes,
70 S ribosomes, and 50 S subunits were collected, and rRNA was isolated
by phenol extraction. The relative amount of mutant 23 S rRNA was
determined by the primer extension method (37) using the 1067U as a
common marker for all constructs. The 5 -32P-labeled
oligonucleotide used as primer was complementary to bases 1069-1087 of
23 S rRNA. Extension products were quantified by densitometry using a
laser scanner (Epson GT-8000) and the WinCAM 2.0 software (Cybertech,
Berlin).
Preparation of Ribosomes
E. coli XL-1/pCI857
transformed with the pNO plasmids were grown at 30 °C in 2 × YT (16 g/liter tryptone, 10 g/liter yeast extract, 5 g/liter NaCl)
supplemented with 0.2 mg/ml ampicillin to A560 = 0.2. Neomycin was omitted in the preparative culture because it
interferes with the thiostrepton resistance of the isolated A1067U
ribosomes,2 but it was added to 0.05 mg/ml
in all stages before. The culture was shifted to 42 °C to induce
synthesis of the plasmid-born rRNA. After 2 h, cells were
collected and lysed by lysozyme (0.5 mg/ml) in buffer A (20 mM Tris-HCl (pH 8.0), 6 mM MgCl2,
100 mM KCl) containing 16% (w/v) sucrose by three
freeze-thaw cycles. S-30 lysate was prepared by centrifugation at
12,000 × g for 30 min in an SA600 rotor (Sorvall). The
volume of the lysate was enlarged four-fold, and the final
concentrations were 20 mM Hepes-KOH (pH 7.6), 6 mM MgCl2, 500 mM NH4Cl,
and 4 mM -mercaptoethanol. The sample was loaded onto a
5-ml sucrose cushion (20% sucrose in 20 mM Hepes-KOH (pH
7.6), 6 mM MgCl2, 500 mM
NH4Cl, 4 mM -mercaptoethanol) in a Beckman
SW-40 rotor, and the ribosomal particles were pelleted by
centrifugation at 55,000 × g for 20 h. The crude
ribosomes were redissolved in standard buffer (20 mM
Hepes-KOH (pH 7.6), 6 mM MgCl2, 150 mM NH4Cl, 4 mM
-mercaptoethanol), loaded onto a 10-30% (w/v) sucrose gradient in
standard buffer, and centrifuged in a Beckman SW-27 rotor for 17 h
at 40,000 × g. The fractions containing 70 S ribosomes
were combined, and the ribosomes were pelleted in a Beckman SW-40 rotor
by centrifugation at 55,000 × g for 20 h. Pellets
were redissolved in standard buffer, shock-frozen in liquid nitrogen,
and stored in aliquots at 80 °C.
Cell-free Protein Synthesis
The protocol essentially
followed Bartetzko and Nierhaus (38) with the modifications of
Rheinberger and Nierhaus (39). The ionic conditions in all steps were
20 mM Hepes-KOH (pH 7.6), 3 mM
MgCl2, 150 mM NH4Cl, 4 mM -mercaptoethanol, 2 mM spermidine, and
0.05 mM spermine. Long poly(U) chains used in this system were isolated over a Sephacryl S-400 gel filtration column. In a volume
of 225 µl, 45 pmol of 70 S ribosomes were incubated with 67.5 pmol of
[14C]AcPhe-tRNAPhe (1,030 dpm/pmol) and 55 µg of poly(U) for 30 min at 37 °C. Where indicated, thiostrepton
was added to a final concentration of 1.6 µM. Two
aliquots of 25 µl containing 5 pmol of 70 S were withdrawn and
filtered over nitrocellulose to determine the amount of
AcPhe-tRNAPhe bound to ribosomes. Poly(Phe) synthesis was
started by mixing the rest of the binding mix (35 pmol of 70 S
ribosomes) with 105 µl of charging mix (preincubated for 2 min,
37 °C) containing 31.5 µl of 100,000 × g
supernatant enzymes freed from tRNA, 0.2 mM GTP, 2 mM ATP, 4 mM phosphenolpyruvate, 10.5 µg of
pyruvate kinase, 350 pmol of tRNAPhe, and 70,000 pmol of
[3H]Phe (22 dpm/pmol). Aliquots of 25 µl were withdrawn
at the indicated times, and the reaction was stopped by hot
trichloroacetic acid precipitation.
RESULTS
Construction of Mutants, in Vivo Effects and Distribution of Mutant
rRNA
The two highly conserved UGG sequences in 23 S rRNA, UGG2582
and UGG2251, are shown in Fig. 1. The mutations C2507U,
2580C, G2581A, and C2507U/G2581A are located in helix 90, and
U2249C, G2250A, C2254U, and C2250A/G2254U are in helix-loop 80. C2507 /G2581A was obtained by chance and was included in the further
analysis. The plasmids pNO2680 (29) and ptac-1 or ptac-2 (31) were used as expression vectors. ptac-1 contains the rrnB operon and, ptac-2 contains the 3 part of the rrnB operon, including the gene for 23 S
rRNA. Both genes are under the control of the
isopropyl-1-thio- -D-galactopyranoside-inducible tac
promoter and contain the mutation A1067U of 23 S rRNA, which confers
resistance to thiostrepton. pNO2680 contains the rrnB operon under the
control of the leftward promoter PL. The promoter was blocked by the heat-labile CI857 repressor that was
supplied by the plasmid pCI857. For the sake of clarity, we
call the pNO2680 plasmid pNO(wt), where wt stands for wild type. The
derivative pNOt carries the A1067U mutation in the 23 S rRNA gene
(pNOt, where t stands for thiostrepton resistance) (30).
Fig. 1.
Schematic representation of the secondary
structure of the domain V of E. coli 23 S rRNA according to
Ref. 44. Helix 80 and helix 90 containing the two highly conserved
UGG sequences are highlighted and enlarged.
Site-specific protections by or cross-links to tRNAs are indicated by
colored arrows, RNA regions cross-linked to puromycin are in
blue, and nucleotides at or near the binding site of
antibiotics identified by cross-links, protections, or resistance
mutations are in red (for review see Refs. 8, 9, 14, 16, and
20)
[View Larger Version of this Image (33K GIF file)]
The effects of mutations under the control of the tac promoter (ptac
derivatives) were tested by streaking the cells on plates in the
absence or presence of
isopropyl-1-thio- -D-galactopyranoside, whereas the
plates with the mutations under the PL promoter (pNOt derivatives) were incubated at 30 or 42 °C. Cells containing the mutation C2507U, G2581A, C2507U/G2581A, and C2507 /G2581A were not
able to form colonies when expressed, i.e. the mutations
were dominant lethal. 2580C showed a reduced size of the colonies when expressed from ptac-2 but grew well when expressed from pNOt. All
the mutations within helix-loop 80 grew normal. The type of induction
had no effect on the expression with the exception of 2580C.
The constructs C2507U, G2581A, C2507U/G2581A, and C2507 /G2581A in
pNOt also showed a reduced growth in liquid cultures. When expression
was induced at a cell density of A560 = 0.2 by
shifting the temperature from 30 to 42 °C, the growth was severely
reduced after one dilution of the culture, and the doubling time was
enlarged by a factor of two to three as compared with that of the wild type or the 1067U control. However, after prolonged incubation at
42 °C, we observed that the cells resumed a normal growth rate, and
after streaking them onto plates, they were also able to form single
colonies at 42 °C. We pursued this effect a little further with the
mutant G2581A. A second site mutation in the plasmid was responsible
for the observed effect.2
The severe growth effects seen with some of the mutants must not
necessarily be due to ribosomes defective in a distinct essential function but rather due to assembly effects preventing the formation of
active ribosomes. A sensitive measure for assembly defects are
sucrose-density profiles of S30 extracts. Assembly defects will lead to
accumulation of precursor particles and distort in a characteristic way
the profile derived from wild-type cells (31). S30 extracts were
prepared from all pNOt constructs; the profiles of all the mutants were
indistinguishable from that of the wild type. An example is shown in
Fig. 2. None of the mutants, therefore, affected the
assembly of 50 S ribosomal subunits.
Fig. 2.
Sucrose gradient patterns from S30 lysates of
XL1-Blue/pCI857/pNOt (A) and XL1-Blue/pCI857/pNOtG2581A
(B).
[View Larger Version of this Image (14K GIF file)]
50 S particles, 70 S ribosomes, and polysomes were isolated from
sucrose gradients as indicated in Fig. 2. The 23 S rRNA was isolated
from all fractions, and the relative amount of plasmid-born 23 S rRNA
was determined using the A1067U mutation as a general marker (primer
extension method, see Ref. 37); this mutation, as mentioned above,
mediates thiostrepton resistance. Generally, the fraction of
plasmid-born 23 S rRNA was around 45% in all three ribosomal
populations. The double mutations C2507U/G2581A and C2507 /G2581A
were reduced in polysomes (27 and 33%, respectively). The fact that
the same fraction of plasmid-born 23 S rRNA was found in the 50 S
subunits and the 70 S ribosomes of all mutants indicate that the mutant
50 S subunits flow as easy into the pool of the 70 S ribosomes as the
wild-type 50 S subunits and that they associate with 30 S subunits as
well as wild-type 50 S subunits. This is another indication that the
ribosomes containing mutant 23 S rRNA have achieved the same level of
assembly maturation as the wild-type 50 S subunits. A reduced relative
amount of the mutant 23 S rRNA in the polysomal fraction indicates that
the functional turnover of mutant 50 S subunits in the ribosomal cycle is impaired. Possible reasons are a hampered capability to form initiation complexes, a reduced processivity, and/or an increased tendency toward frameshifts, which will cause a premature termination at out-of-frame stop codons.
A summary of the growth effects and the relative amounts of the various
mutant 23 S rRNAs in the 50 S subunits, 70 S ribosomes, and the
polysomes is given in Table I.
Functional Studies
One can anticipate that a mutation that
exclusively affects the PTF center should not impair tRNA binding since
only a small fraction of the A and P sites belong to the PTF center.
Therefore, a normal tRNA binding to the A and P sites and a block in
the PTF activity would be important indications for the specificity of
the provoked ribosomal defect. Various functional tests were performed
in this and the accompanying study (28) that require a tRNA at a
specific site but differ in their ionic conditions. Therefore, 70 S
ribosomes were isolated from all mutants and analyzed for binding of
AcPhe-tRNA under the various conditions. Poly(U) and the
heteropolymeric MF-mRNA, which is 46 nucleotides long and contains
the codons AUG-UUC only once in the middle (40), were used as templates
(Table II). It is clear that in all cases mutant and
wild-type ribosomes bound the tRNA to the same extent and that,
therefore, none of the mutations alters the basic interactions between
the sites (A and P) and tRNAs.
The next step was to check whether the mutations influence the overall
elongation cycle that can be tested with the
poly(U)-dependent poly(Phe) synthesis. An in
vitro system with near in vivo characteristics concerning speed and accuracy was used to look at the influence of the
mutations (38, 39). [14C]AcPhe-tRNA was bound to
poly(U)-programmed 70 S ribosomes, and the incorporation of
[3H]Phe was followed kinetically. In order to distinguish
between chromosomal- and plasmid-born 23 S rRNA, the assays were
performed in the presence or absence of thiostrepton (41). The effect of the addition of thiostrepton can be studied by comparing
thiostrepton-sensitive ribosomes (wild-type ribosomes derived from
pNO(wt)) with thiostrepton-resistant ribosomes (A1067U, derived from
pNOt). The overall incorporation of Phe per ribosome is comparable for
both ribosome preparations (Fig. 3, A and
B). Addition of thiostrepton abolishes completely the
activity of wild-type ribosomes (first panel), whereas the A1067U mutant still shows half of the activity in good agreement with
the 46% fraction of plasmid-born ribosomes (Table I). Similar results
are obtained when the hot TCA precipitable AcPhe residues are
considered (second panel). Under this condition, AcPhe
precipitates only if it heads a chain of oligo(Phe) with a minimal
length of three Phe residues (42). The number of precipitable AcPhe
residues directly gives the number of ribosomes active in poly(Phe)
synthesis since ribosomes do not recycle on poly(U) but translate as
far as possible toward the 3 -end. Furthermore, under the conditions used, ribosomes with AcPhe-tRNA initiate poly(Phe) synthesis much faster than ribosomes without (38, 43). The statistical length of the
poly(Phe) chains can thus be simply calculated from both the total Phe
incorporation and the number of precipitable AcPhe residues
(third panel), since practically all poly(Phe) chains carry
an AcPhe residue at their N-termini. Fig. 3 shows that in the presence
of thiostrepton, the chain growth of poly(Phe) occurs nearly as fast as
that of the total ribosome population in the absence of thiostrepton,
i.e. the A1067U mutation has practically no consequence for
the ribosomal elongation cycle in our test systems.
Fig. 3.
Kinetics of poly(U)-dependent
poly(Phe) synthesis. Ac[14C]Phe-tRNA was prebound to
the P sites of poly(U)-programmed 70 S ribosomes, and the incorporation
of [3H]Phe was measured. Kinetics were performed in the
absence (open circles) and in the presence of 1 µM thiostrepton (filled circles). The panel at
the top shows the overall poly(Phe) synthesis given as Phe
incorporation per ribosome. The panel in the middle
indicates the hot TCA precipitable AcPhe residues per ribosome, which
is the fraction of ribosomes participating in the poly(Phe) synthesis. The bottom panel presents the ratio Phe/AcPhe in the hot TCA
precipitable material, which corresponds to the statistical chain
length of the synthesized poly(Phe) chains.
[View Larger Version of this Image (32K GIF file)]
Results obtained with the mutants G2581A and C2507U/G2581A are
demonstrated in Fig. 3, C and D. In the presence
of thiostrepton, the total Phe incorporation per 70 S ribosome
(first panel) is strongly reduced for the G2581A ribosomes
compared with the control ribosomes A1067U. The overall Phe
incorporation is the product of the active ribosomes (second
panel) and the chain length (Phe/AcPhe; third panel).
Both factors are significantly reduced. Furthermore, the average speed
of elongation within the first 20 s is reduced by a factor of two
for the mutant ribosomes (Fig. 4C). It
follows that these mutant ribosomes are strongly affected in peptide
synthesis and that the processivity is significantly impaired. The
double mutant shows no significant activity in this assay.
Fig. 4.
Summary of the results of the poly(Phe)
synthesis obtained with the various constructs. The poly(Phe)
synthesis was described in detail for some ribosome preparations in
Fig. 3. A, Phe incorporation in the presence of thiostrepton
relative to the pNOt derived ribosomes carrying only the A1067U
mutation. The average value for all time points 20 s from
at least two independent experiments is shown, and the standard
deviation is given. B, the active fractions of ribosomes
(AcPhe/70 S). All time points 20 s of the kinetics were
used for the calculation. The total height of the columns represents
the active fraction without drug. The standard deviation of the active
fractions was around ± 10%. The thiostrepton-sensitive fraction
(thio sensitive) represented by the lower columns was obtained as the
difference between the active fraction of ribosomes without
thiostrepton and the active fraction in the presence of thiostrepton.
The numbers over the columns indicate the ratio of
thiostrepton-resistant active fraction versus the
thiostrepton-sensitive fraction, relative to the control ribosomes
carrying only the A1067U mutation. 56% of the active fraction of the
control ribosomes were resistant against thiostrepton; 100%
corresponds, therefore, to a ratio 56/44 = 1.27. C, the
relative average velocity of the growth of the chain length Phe/AcPhe
within the first 20 s in the presence of thiostrepton derived from
a regression line (see Fig. 3, third panel). The control
ribosomes (relative velocity of 100) derived from pNOt had an average
velocity of 1.3 Phe/AcPhe/sec in the presence of thiostrepton.
[View Larger Version of this Image (26K GIF file)]
Fig. 4 shows a summary of the relative Phe incorporation per 70 S
ribosome in the presence of thiostrepton compared with the corresponding activity without the drug (Fig. 4A), the
active fraction of ribosomes in the presence and absence of the drug (Fig. 4B), and the average velocity of the ribosomes with
plasmid-encoded 23 S rRNA compared with that of the control ribosomes
A1067U (Fig. 4C). Note that the thiostrepton-sensitive part
of the active fraction of ribosomes (Fig. 4B) is hardly
affected by all ribosomes derived from pNOt derivatives. These
thiostrepton-sensitive signals correspond to the wild-type fraction
within the mixed population of ribosomes and represent a good internal
control that only the mutated ribosomes are affected.
All mutations in the helix 90 severely affect poly(Phe) synthesis. The
G2581A and 2580C ribosomes show a three-fold reduced Phe
incorporation (Fig. 4A) caused by a reduction of the active fraction (Fig. 4B), and the elongation rate was retarded by
a factor of two (Fig. 4C). As already mentioned, the
C2507U/G2581A and also the C2507 /G2581A double mutants are
practically inactive in the poly(U) translation system. The effects
seen with the mutations in the helix-loop 80 are less pronounced but
still significant. All mutations show a slightly reduced speed of
elongation (Fig. 4C). The relatively strongest effect is
seen with the G2250A mutation concerning the overall Phe incorporation
(Fig. 4A). This effect is mainly due to a reduction of the
active fraction of ribosomes (Fig. 4B).
DISCUSSION
In this study and in the following paper (28), regions of helices
80 and 90 of the 23 S rRNA have been investigated for their possible
involvement in the PTF reaction. Both regions contain a UGG sequence
that is universally conserved among non-mitochondrial 23 S-type rRNA
and has, therefore, the potential to bind the universal conserved
CCA-3 -end of tRNAs via base pairing. Only a few mitochondrial 23 S-type rRNA from animals contain only two out of the three otherwise
universally conserved UGG sequences (44); the corresponding ribosomes
synthesize proteins with low efficiency and translate only a few
mRNAs (45).
In agreement with the high evolutionary conservation of both sequences,
all mutations tested show some defect in the in vitro poly(Phe) translation system. However, none of the mutations introduced in helix 80 (U2249C, G2250A, C2254U, and G2250A/C2254U) affects the
growth of the bacteria. This is not necessarily a contradiction. For
example, the G2661C mutation of 23 S rRNA has no effect on bacterial
growth until expressed in a mutant S12 background (46), but the 23 S
rRNA mutation alone significantly reduces the translational efficiency
(47). As shown in the following paper (28), the mutations introduced in
helix 80 only slightly reduce the puromycin reaction. Therefore, none
of the changed bases is essential for peptide bond formation. The
effects of these mutations on the poly(Phe) synthesis is not caused by
a specific block of a single elongation step, but rather the kinetic
efficiency of A site binding, the translocation reaction, or the
processivity might be affected. Among the altered bases is C2254, a
base protected by an A site-bound tRNA (18). Our data suggest that this
protection is either an indirect effect or, alternatively, the
interaction between tRNA and 23 S rRNA at this position is not
essential. Furthermore, weakening or destruction of the base pair
G2250-C2254 (i. e. the mutations C2254U and G2250A,
respectively) have no disastrous effect on any of the ribosomal
activities tested. It follows that this base pair does not seem to be
required for functions of the ribosomal elongation cycle and might not
even exist within the ribosome.
In contrast, most of the mutations within helix 90 (C2507U, G2581A,
C2507U/G2581A, and C2507 /G2581A) have a dominant lethal phenotype.
At least the single mutations do not affect the assembly of the 50 S
subunits and the flow of the assembled subunit into the polysome
fraction. Poly(Phe) synthesis is severely impaired. In the following
paper, we were able to demonstrate that the helix 90 mutations G2581A,
C2507U/G2581A, and C2507 /G2581A completely block the puromycin
reaction, and the mutation 2580C drastically impairs this reaction
(28). Also C2507U reduces the AcPhe-puromycin formation by
approximately 50%.
Comparison of the poly(Phe) translation data with the results of the
puromycin reactions (28) raises the following question. How is it
possible that a ribosomal activity essential for protein synthesis such
as peptide-bond formation is completely blocked in assay systems
specifically testing this activity, whereas in systems testing the
overall elongation such as poly(Phe) synthesis a significant although
residual activity can be detected?
Let us consider the G2581A mutation. In contrast to the total
inhibition of the puromycin reaction, there is a strongly decreased but
still significant activity of this mutant 70 S in the poly(U) translation system (~30% compared with the 70 S derived from pNOt). Various factors have to be considered for an explanation of this apparent discrepancy. First of all, one has to consider that the PTF
activity is not the rate-limiting step of elongation and is much faster
than A site occupation or translocation. It follows that even a severe
effect on the rate of the PTF activity is not necessarily detected in a
complete translation system. Second, the puromycin reaction takes place
at 0 °C and the poly(U) translation at 37 °C. The higher
temperature might cause a higher flexibility of the PTF center, thus
partially overcoming the negative effect of the mutation. And third,
the reactants in the poly(U) translation system, peptidyl-tRNA and
aminoacyl-tRNA, are bound to the ribosome mainly outside of the PTF
center and are tightly fixed. If the mutation weakens the binding of
the P site-bound CCA-3 -end but does not affect the stably fixed
aminoacyl-tRNA at the A site, peptidyl transfer will occur when the
loosely bound peptidyl residue has accidentally reached the correct
position. In contrast, puromycin has only a low binding affinity to the
A site (1.35 × 103 M 1)
(48). Therefore, the sticking time is very short and most of the
encounters of puromycin with the ribosome should be unproductive if the
peptidyl residue is not tightly fixed at the PTF center. This feature
of the puromycin reaction explains why a mutant can affect the
puromycin reaction much more severely than an overall protein synthesis
system such as poly(Phe) synthesis. Furthermore, a binding analysis of
ligands for the A and P site regions of the PTF center revealed a
positive cooperativity between these sites (49, 50). This cooperativity
might be destroyed by a mutation that weakens the binding of the P site
bound CCA-3 -end, therefore further reducing the low affinity of
puromycin or a fragment that only binds to the A site region of the PTF
center.
Effects of this kind were also observed with other mutants,
i.e. a strong or even complete inhibition in an assay system
testing a partial but essential reaction for protein synthesis in
contrast to an almost normal growth or activity in a complete
translation system,. The G2583A, G2583C, and G2505A mutations are
active in a poly(U) translation system but are inactive in
AcPhe-puromycin formation.3 The A2503G
mutation did not affect growth unless erythromycin was added, but the
derived ribosomes were inactive or nearly inactive in a fragment assay
(24). Similar observations also have been reported with peptidyl-tRNA
mutations. A mutated CCA-3 -end at position 74 abolished the activity
as a PTF donor in a fragment reaction (27), but the corresponding tRNAs
are active in vivo (51). Mutations at position A-76 also
affect the fragment reaction more (27) than an in vitro
translation system (52).
It is therefore likely that the effects of the helix 90 mutations on
poly(Phe) synthesis are caused by a severe distortion of the active
center of the ribosomal PTF (28). The data clearly indicate that not
only the single-stranded 23 S rRNA regions in the central loop of
domain V are of high importance for ribosomal function but also the
nucleotides at the top of helix 90.
FOOTNOTES
*
This work was supported by DFG Grant Ni174/7-1 and EC Grant
ERBCIPA CT930136. The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Tel.:
49-30-8413-1217; Fax: 49-30-8413-1380; E-mail:
nierhaus_kh{at}mpimg-berlin-dahlem.mpg.de.
1
The abbreviation used is: PTF,
peptidyltransferase.
2
C. M. T. Spahn and K. H. Nierhaus, unpublished
result.
3
U. Saarma, C. M. T. Spahn, K. H. Nierhaus, and
J. Remme, unpublished result.
Acknowledgments
We are grateful to Drs. C. O'Neal, N. Burkhardt, R. Jünemann, and G. Diedrich for help and discussion
and to J.-U. Bittner for expert assistance.
REFERENCES
-
Monro, R. E.
(1967)
J. Mol. Biol.
26,
147-151
[CrossRef][Medline]
[Order article via Infotrieve]
-
Maden, B. E. H., Traut, R. R., and Monro, R. E.
(1968)
J. Mol. Biol.
35,
333-345
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hampl, H., Schulze, H., and Nierhaus, K. H.
(1981)
J. Biol. Chem.
256,
2284-2288
[Free Full Text]
-
Schulze, H., and Nierhaus, K. H.
(1982)
EMBO J.
1,
609-613
[Medline]
[Order article via Infotrieve]
-
Franceschi, F. J., and Nierhaus, K. H.
(1990)
J. Biol. Chem.
265,
16676-16682
[Abstract/Free Full Text]
-
Noller, H. F., Hoffahrt, V., and Zimniak, L.
(1992)
Science
256,
1416-1419
[Abstract/Free Full Text]
-
Noller, H. F.
(1993)
J. Bacteriol.
175,
5297-5300
[Free Full Text]
-
Noller, H. F.
(1991)
Annu. Rev. Biochem.
60,
191-227
[Medline]
[Order article via Infotrieve]
-
Brimacombe, R.
(1995)
Eur. J. Biochem.
230,
365-383
[Medline]
[Order article via Infotrieve]
-
Gutell, R. R.
(1993)
in
The Translational Apparatus: Structure, Function, Regulation, Evolution (Nierhaus, K. H., Franceschi, F., Subramanian, A. R., Erdmann, V. A., and Wittmann-Liebold, B., eds), pp. 477-488, Plenum Publishing Corp., New York
-
Egebjerg, J., Larsen, N., and Garrett, R. A.
(1990)
in
The Ribosome: Structure, Function & Evolution (Hill, W. E., Dahlberg, A., Garrett, R. A., Moore, P. B., Schlessinger, D., and Warner, J. R., eds), pp. 168-179, American Society for Microbiology, Washington, D. C.
-
Barta, A., Steiner, G., Brosius, J., Noller, H. F., and Kuechler, E.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
3607-3611
[Abstract/Free Full Text]
-
Steiner, G., Kuechler, E., and Barta, A.
(1988)
EMBO J.
7,
3949-3955
[Medline]
[Order article via Infotrieve]
-
Cooperman, B. S., Weitzmann, C. J., and Fernández, C. L.
(1990)
in
The Ribosome: Structure, Function & Evolution (Hill, W. E., Dahlberg, A., Garrett, R. A., Moore, P. B., Schlessinger, D., and Warner, J. R., eds), pp. 491-501, American Society for Microbiology, Washington, D. C.
-
Stade, K., Riens, S., Bochkariov, D., and Brimacombe, R.
(1994)
Nucleic Acids Res.
22,
1394-1399
[Abstract/Free Full Text]
-
Cundliffe, E.
(1990)
in
The Ribosome: Structure, Function & Evolution (Hill, W. E., Dahlberg, A., Garrett, R. A., Moore, P. B., Schlessinger, D., and Warner, J. R., eds), pp. 479-490, American Society for Microbiology, Washington, D. C.
-
Douthwaite, S., Vester, B., Aagaard, C., and Rosendahl, G.
(1993)
in
The Translational Apparatus: Structure, Function, Regulation, Evolution (Nierhaus, K. H., Franceschi, F., Subramanian, A. R., Erdmann, V. A., and Wittmann-Liebold, B., eds), pp. 339-346, Plenum Publishing Corp., New York
-
Moazed, D., and Noller, H. F.
(1989)
Cell
57,
585-597
[CrossRef][Medline]
[Order article via Infotrieve]
-
Moazed, D., and Noller, H. F.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
3725-3728
[Abstract/Free Full Text]
-
Rodriguez-Fonseca, C., Amils, R., and Garrett, R. A.
(1995)
J. Mol. Biol.
247,
224-235
[CrossRef][Medline]
[Order article via Infotrieve]
-
Gregory, S. T., Lieberman, K. R., and Dahlberg, A. E.
(1994)
Nucleic Acids Res.
22,
279-284
[Abstract/Free Full Text]
-
Lieberman, K. R., and Dahlberg, A. E.
(1994)
J. Biol. Chem.
269,
16163-16169
[Abstract/Free Full Text]
-
Samaha, R. R., Green, R., and Noller, H. F.
(1995)
Nature
377,
309-314
[CrossRef][Medline]
[Order article via Infotrieve]
-
Porse, B. T., and Garrett, R. A.
(1995)
J. Mol. Biol.
249,
1-10
[CrossRef][Medline]
[Order article via Infotrieve]
-
Krayevsky, A. A., and Kukhanova, M. K.
(1979)
Prog. Nucleic Acid Res. Mol. Biol.
23,
1-51
[Medline]
[Order article via Infotrieve]
-
Chladek, S., and Sprinzl, M.
(1985)
Angew. Chem.
97,
377-398
-
Tamura, K.
(1994)
FEBS Lett.
353,
173-176
[CrossRef][Medline]
[Order article via Infotrieve]
-
Spahn, C. M. T., Schäfer, M. A., Krayevsky, A. A., and Nierhaus, K. H.
(1996)
J. Biol. Chem.
271,
32857-32862
[Abstract/Free Full Text]
-
Gourse, R. L., Stark, M. J. R., and Dahlberg, A. E.
(1983)
Cell
32,
1347-1354
[CrossRef][Medline]
[Order article via Infotrieve]
-
Thompson, J., Cundliff, E., and Dahlberg, A. E.
(1988)
J. Mol. Biol.
203,
457-465
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lewicki, B. T. U., Margus, T., Remme, J., and Nierhaus, K. H.
(1993)
J. Mol. Biol.
231,
581-593
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kunkel, T.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
488-492
[Abstract/Free Full Text]
-
Sanger, F., Nickelsen, F., and Coulson, A. R.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
5463-5467
[Abstract/Free Full Text]
-
Sambrook, J., Fritsch, E. F., and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Smith, J. A., Seidmann, J. G., and Struhl, K.
(1991)
Current Protocols in Molecular Biology, John Wiley & Sons, Inc., NY
-
Inoue, H., Nojima, H., and Okayama, H.
(1990)
Gene (Amst.)
96,
23-28
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sigmund, C. D., Ettayebi, M., Borden, A., and Morgan, E. A.
(1988)
Methods Enzymol.
164,
673-690
[Medline]
[Order article via Infotrieve]
-
Bartetzko, A., and Nierhaus, K. H.
(1988)
Methods Enzymol.
164,
650-658
[Medline]
[Order article via Infotrieve]
-
Rheinberger, H. J., and Nierhaus, K. H.
(1990)
Eur. J. Biochem.
193,
643-650
[Medline]
[Order article via Infotrieve]
-
Triana-Alonso, F. J., Dabrowski, M., Wadzack, J., and Nierhaus, K. H.
(1995)
J. Biol. Chem.
270,
6298-6307
[Abstract/Free Full Text]
-
Saarma, U., and Remme, J.
(1992)
Nucleic Acids Res.
20,
3147-3152
[Abstract/Free Full Text]
-
Pestka, S.
(1970)
Arch. Biochem. Biophys.
136,
89-96
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wagner, E. G. H., Jelenc, P. C., Ehrenberg, M., and Kurland, C. G.
(1982)
Eur. J. Biochem.
122,
193-197
[Medline]
[Order article via Infotrieve]
-
Gutell, R. R., Gray, M. W., and Schnare, M. N.
(1993)
Nucleic Acids Res.
21,
3055-3074
[Free Full Text]
-
Takemoto, C., Koike, T., Yokogawa, T., Benkowski, L., Spremulli, L. L., Ueda, T., Nishikawa, K., and Watanabe, K.
(1995)
Biochimie (Paris)
77,
104-108
[Medline]
[Order article via Infotrieve]
-
Tapprich, W. E., and Dahlberg, A. E.
(1990)
EMBO J.
9,
2649-2655
[Medline]
[Order article via Infotrieve]
-
Bilgin, N., and Ehrenberg, M.
(1994)
J. Mol. Biol.
235,
813-824
[CrossRef][Medline]
[Order article via Infotrieve]
-
Welch, M., Chastang, J., and Yarus, M.
(1995)
Biochemistry
34,
385-390
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ulbrich, B., Mertens, G., and Nierhaus, K. H.
(1978)
Arch. Biochem. Biophys.
190,
149-154
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bourd, S. B., Kukhanova, M. K., Gottikh, B. P., and Krayevsky, A. A.
(1983)
Eur. J. Biochem.
135,
465-470
[Medline]
[Order article via Infotrieve]
-
O'Connor, M., Willis, N. M., Bossi, L., Gesteland, R. F., and Atkins, J. F.
(1993)
EMBO J.
12,
2559-2566
[Medline]
[Order article via Infotrieve]
-
Liu, M., and Horowitz, J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10389-10393
[Abstract/Free Full Text]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Virumae, U. Saarma, J. Horowitz, and J. Remme
Functional Importance of the 3'-Terminal Adenosine of tRNA in Ribosomal Translation
J. Biol. Chem.,
June 28, 2002;
277(27):
24128 - 24134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chowdhury, S. Pal, J. Ghosh, and C. DasGupta
Mutations in domain V of the 23S ribosomal RNA of Bacillus subtilis that inactivate its protein folding property in vitro
Nucleic Acids Res.,
March 1, 2002;
30(5):
1278 - 1285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Nitta, Y. Kamada, H. Noda, T. Ueda, and K. Watanabe
Reconstitution of Peptide Bond Formation with Escherichia coli 23S Ribosomal RNA Domains
Science,
July 31, 1998;
281(5377):
666 - 669.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. S. Iordanov, D. Pribnow, J. L. Magun, T.-H. Dinh, J. A. Pearson, and B. E. Magun
Ultraviolet Radiation Triggers the Ribotoxic Stress Response in Mammalian Cells
J. Biol. Chem.,
June 19, 1998;
273(25):
15794 - 15803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M.T. Spahn, M. A. Schafer, A. A. Krayevsky, and KnudH. Nierhaus
Conserved Nucleotides of 23S rRNA Located at the Ribosomal Peptidyltransferase Center
J. Biol. Chem.,
December 20, 1996;
271(51):
32857 - 32862.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|